Literature DB >> 11292744

C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes.

F T Liang1, L C Bowers, M T Philipp.   

Abstract

VlsE, the variable surface antigen of Borrelia burgdorferi, contains two invariable domains located at the amino and carboxyl terminal ends, respectively, and a central variable domain. In this study, both immunogenicity and antigenic conservation of the C-terminal invariable domain were assessed. Mouse antiserum to a 51-mer synthetic peptide (Ct) which reproduced the entire sequence of the C-terminal invariable domain of VlsE from B. burgdorferi strain B31 was reacted on immunoblots with whole-cell lysates extracted from spirochetes of 12 strains from the B. burgdorferi sensu lato species complex. The antiserum recognized only VlsE from strain B31, indicating that epitopes of this domain differed among these strains. When Ct was used as enzyme-linked immunosorbent assay (ELISA) antigen, all of the seven monkeys and six mice that were infected with B31 spirochetes produced a strong antibody response to this peptide, indicating that the C-terminal invariable domain is immunodominant. None of 12 monkeys and only 11 of 26 mice that were infected with strains other than B31 produced a detectable anti-Ct response, indicating a limited antigenic conservation of this domain among these strains. Twenty-six of 33 dogs that were experimentally infected by tick inoculation were positive by the Ct ELISA, while only 5 of 18 serum samples from dogs clinically diagnosed with Lyme disease contained detectable anti-Ct antibody. Fifty-seven of 64 serum specimens that were collected from American patients with Lyme disease were positive by the Ct ELISA, while only 12 of 21 European samples contained detectable anti-Ct antibody. In contrast, antibody to the more conserved invariable region IR(6) of VlsE was present in all of these dog and human serum samples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292744      PMCID: PMC98280          DOI: 10.1128/IAI.69.5.3224-3231.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Antigenic variation in African trypanosomes.

Authors:  L H Van der Ploeg; K Gottesdiener; M G Lee
Journal:  Trends Genet       Date:  1992-12       Impact factor: 11.639

Review 2.  Molecular genetics of antigenic variation.

Authors:  P Borst
Journal:  Immunol Today       Date:  1991-03

3.  Crossreacting determinants in the C-terminal region of trypanosome variant surface antigens.

Authors:  G A Cross
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

Review 4.  Molecular basis for trypanosome antigenic variation.

Authors:  P Borst; G A Cross
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

5.  Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia.

Authors:  J T Meier; M I Simon; A G Barbour
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice.

Authors:  L Gern; U E Schaible; M M Simon
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

7.  Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae.

Authors:  P Hagblom; E Segal; E Billyard; M So
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

8.  Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.

Authors:  M T Philipp; M K Aydintug; R P Bohm; F B Cogswell; V A Dennis; H N Lanners; R C Lowrie; E D Roberts; M D Conway; M Karaçorlu; G A Peyman; D J Gubler; B J Johnson; J Piesman; Y Gu
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides.

Authors:  P A Barstad; J E Coligan; M G Raum; A G Barbour
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Strain-specific and common epitopes of gonococcal pili.

Authors:  J B Rothbard; R Fernandez; G K Schoolnik
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  20 in total

1.  Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.

Authors:  Carl V Hamby; Marta Llibre; Sandeepa Utpat; Gary P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Serum antibodies to whole-cell and recombinant antigens of Borrelia burgdorferi in cottontail rabbits.

Authors:  Louis A Magnarelli; Steven J Norris; Erol Fikrig
Journal:  J Wildl Dis       Date:  2012-01       Impact factor: 1.535

3.  Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis.

Authors:  Ulrike Schulte-Spechtel; Gisela Lehnert; Gaby Liegl; Volker Fingerle; Christiane Heimerl; Barbara J B Johnson; Bettina Wilske
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector.

Authors:  K J Indest; J K Howell; M B Jacobs; D Scholl-Meeker; S J Norris; M T Philipp
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 6.  vls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework Heterogeneity.

Authors:  Steven J Norris
Journal:  Microbiol Spectr       Date:  2014-12

7.  Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.

Authors:  Fang Ting Liang; Jun Yan; M Lamine Mbow; Steven L Sviat; Robert D Gilmore; Mark Mamula; Erol Fikrig
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.

Authors:  Thomas P O'Connor; Kathy J Esty; Jancy L Hanscom; Paulette Shields; Mario T Philipp
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.

Authors:  Monica E Embers; Mary B Jacobs; Barbara J B Johnson; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

10.  Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.

Authors:  John V McDowell; Shian-Ying Sung; Linden T Hu; Richard T Marconi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.